| Name | (3S,5S)-Atorvastatin Sodium Salt |
|---|---|
| Synonyms |
(S,S)-Atorvastatin
3S,5S-Atorvastatin Atorvastatin Impurity 25 |
| Description | (3S,5S)-Atorvastatin is a inactive enantiomer of Atorvastatin. (3S,5S)-Atorvastatin can activate pregnane X receptor (PXR). Atorvastatin is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Pregnane X receptor (PXR)[1] |
| In Vitro | Atorvastatin and its inactive enantiomer (3S,5S)-Atorvastatin increases CYP2B and CYP3A mRNA content with equal ability[1]. (3S,5S)-Atorvastatin in 100 μM concentrations induces luciferase activity with an EC50 of 12.4 μM[2]. Addition of (3S,5S)-Atorvastatin to the 2-formylphenylboronicacid (FPBA)/l-tryptophanol mixture induces an intensity enhancement of l-tryptophanol florescence[3]. |
| References |
| Melting Point | 182-184ºC |
|---|---|
| Molecular Formula | C33H35FN2O5 |
| Molecular Weight | 558.64000 |
| Exact Mass | 558.25300 |
| PSA | 111.79000 |
| LogP | 6.38660 |
| Storage condition | -20°C |
|
~%
501121-34-2 |
| Literature: Collection of Czechoslovak Chemical Communications, , vol. 73, # 2 p. 229 - 246 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |